drugset / Trial / NCT02034630
Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the outcome of hematopoietic stem cell transplantation using targeted busulfan, fludarabine conditioning regimen in genetic rare disease
Timeline
- Start
- 2014-07-21
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Busulfan | Small molecule | 80 mg/m2 | Intravenous |
| Subject | Busulfan | Small molecule | 120 mg/m2 | Intravenous |